New Leadership at Bioretec
Bioretec Ltd has announced a significant leadership change with the appointment of Sarah van Hellenberg Hubar-Fisher as the interim CEO. Her experience and vision are set to steer the company into a new era of innovation and growth.
Expertise and Future Goals
Sarah van Hellenberg Hubar-Fisher brings over 23 years of extensive experience in global healthcare and technology introduction to her new role. This depth of knowledge will be instrumental in propelling Bioretec to a leading position in the market for absorbable orthopedic implants. With her at the helm, we can expect exciting developments in the company's product lines and overall strategic direction.
Commitment to Progress
Bioretec's Board of Directors expressed confidence in her leadership approach, emphasizing the company's commitment to market growth and patient care. "Bioretec is poised for market leadership, and our organization is ready to promote this reality by providing reliable absorbable implants for patients," said Hubar-Fisher, highlighting her enthusiasm for the company's potential.
Continuing Innovations in Orthopedic Treatment
Bioretec is well-known for its pioneering work in biodegradable orthopedic implants, which are essential for enhancing patient outcomes in fracture treatment. By utilizing advanced materials like magnesium alloy and hybrid composites in their RemeOs™ product line, Bioretec continues to redefine surgical standards and patient care.
The RemeOs™ Product Line
The RemeOs™ implants are designed to be absorbed by bone, eliminating the need for removal surgeries, thus streamlining the healing process. Such innovative solutions position Bioretec as a frontrunner in the global orthopedic trauma and spine market, with a substantial opportunity to capture a portion of the over USD 9 billion industry.
Board of Directors' Stance
With Hubar-Fisher also serving on the Board of Directors and the Audit Committee, her dual role promises a seamless transition and continuity in the company's executive strategy. The Board is actively engaged in the search for a permanent CEO, ensuring that the right direction remains at the forefront of Bioretec's mission.
About Bioretec
Bioretec is a Finnish medical device company known for its innovative biodegradable orthopedic implants used in over 40 countries worldwide. The company's dedication to developing advanced surgical solutions has established it as a key player in orthopedic care, particularly in relation to enhancing healing time and outcomes after surgery.
Contact for Further Information
For further inquiries, please reach out to Kustaa Poutiainen, Chair of the Board, at +358 40 042 4506. The organization is also supported by Nordic Certified Adviser AB, reachable at +46 70 551 67 29.
Frequently Asked Questions
Who is the new interim CEO of Bioretec?
Sarah van Hellenberg Hubar-Fisher has been appointed as the interim CEO of Bioretec.
What experience does Sarah bring to Bioretec?
She has over 23 years of experience in global healthcare and technology introduction, which will be vital for Bioretec's growth.
What is Bioretec known for?
Bioretec specializes in biodegradable orthopedic implants, enhancing the healing process and patient outcomes in surgical treatments.
What are RemeOs™ implants?
The RemeOs™ implants are biodegradable devices that are absorbed by the body, eliminating the need for removal surgeries.
How can I contact Bioretec for more information?
You can contact Kustaa Poutiainen, Chair of the Board, at +358 40 042 4506 for further inquiries.
